{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03278691",
            "orgStudyIdInfo": {
                "id": "IRB # 1072359"
            },
            "organization": {
                "fullName": "Ascension South East Michigan",
                "class": "OTHER"
            },
            "briefTitle": "Ketorolac on Posterior Thoracolumbar Spinal Fusions",
            "officialTitle": "The Effect of Ketorolac on Posterior Thoracolumbar Spinal Fusions: a Prospective Randomized Controlled Trial",
            "therapeuticArea": [
                "Other"
            ],
            "study": "ketorolac-on-posterior-thoracolumbar-spinal-fusions"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2017-10-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2017-08-24",
            "studyFirstSubmitQcDate": "2017-09-08",
            "studyFirstPostDateStruct": {
                "date": "2017-09-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-04-18",
            "lastUpdatePostDateStruct": {
                "date": "2023-04-20",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Ascension South East Michigan",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "To determine is low-dose ketorolac use in the early post-operative period (within 48 hours) provides adequate analgesia without long term adverse effect on spinal fusion rates when compared to post-operative analgesia without the use of NSAIDs."
        },
        "conditionsModule": {
            "conditions": [
                "Thoracolumbar Spinal Fusions"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 600,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Drug: Placebo Saline 1 ml IV Q6H",
                    "interventionNames": [
                        "Drug: Saline"
                    ]
                },
                {
                    "label": "Intervention",
                    "type": "EXPERIMENTAL",
                    "description": "Ketorolac 15 mg (15mg/ml) IV Q6H",
                    "interventionNames": [
                        "Drug: Ketorolac"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Saline",
                    "description": "1 ml saline IV Q6H",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ketorolac",
                    "description": "15 mg (15 mg/ml) IV Q6H",
                    "armGroupLabels": [
                        "Intervention"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Fusion Construct X-Ray",
                    "description": "Each fusion level will be evaluated individually and as part of the complete fusion construct. Fusion will be evaluated by blinded independent neuroradiologists using XR.",
                    "timeFrame": "6 months postoperatively"
                },
                {
                    "measure": "Fusion Construct X-Ray",
                    "description": "Each fusion level will be evaluated individually and as part of the complete fusion construct. Fusion will be evaluated by blinded independent neuroradiologists using XR.",
                    "timeFrame": "12 months postoperatively"
                },
                {
                    "measure": "Fusion Construct X-Ray",
                    "description": "Each fusion level will be evaluated individually and as part of the complete fusion construct. Fusion will be evaluated by blinded independent neuroradiologists using XR.",
                    "timeFrame": "24 months postoperatively"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Visual Analogue Scale (VAS) for pain",
                    "description": "* Patient will be given the VAS on the source document in order to draw on the scale\n* Blinded investigators",
                    "timeFrame": "Every 8 hours x 48 hours postoperatively"
                },
                {
                    "measure": "Length of Stay (LOS)",
                    "description": "-Measured in days (24 hours)\n\n\u2022 Automatic data capture on discharge by the hospital EMR",
                    "timeFrame": "12 months postoperatively"
                },
                {
                    "measure": "Morphine equivalent doses",
                    "description": "-Non-study narcotics taken by patients on the floor are converted to morphine equivalent doses\n\n* Morphine equivalent doses are compared between the two groups daily for the first 48h\n* Data extracted from hospital EMR on discharge",
                    "timeFrame": "12 months postoperatively"
                },
                {
                    "measure": "Complications/Adverse events",
                    "description": "-Ketorolac-related short term in-hospital complications: GI ulceration and bleeding, GI perforation, PO bleeding, acute renal failure, anaphylactic/anaphylactoid reactions, liver failure\n\n* Collected by investigators daily during round\n* Document on the source document",
                    "timeFrame": "12 months postoperatively"
                },
                {
                    "measure": "Quality of life - long term",
                    "description": "Oswestry Disability Index (ODI)\n\n* We will administer validated scales (ODI)\n* Face-to -face interview during clinic visit",
                    "timeFrame": "12 months and/or 24 months postoperatively"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Over 18 years of age\n* Elective thoracolumbar posterior lumbar instrumented interbody fusion\n* Minimally invasive spine surgery (MIS)\n* 3 or fewer levels\n* Bone Morphogenetic Protein (BMP) use in interbody fusion (1.05mg/level or less)\n* Consent to study participation\n\nExclusion Criteria:\n\n* Active tobacco smoker or history of tobacco smoking in the past 6 weeks\n* Previous history of surgery at operative level(s)\n* History of chronic inflammatory/rheumatological condition\n* History of systemic steroid use in the past 3 months\n* Auto/Workers' compensation patients\n* Traumatic pathology at the operative levels\n* Infection at the operative levels\n* Tumor at the operative levels\n* Major psychiatric illness as diagnosed by psychiatrists and on major anti- psychotic/depressants\n* Patients on chemotherapeutic agents in the last 6 months\n* Patients who has a history of allergy to Ketorolac\n* Patients with a history of chemical addiction requiring professional rehabilitation and/or assistance\n* Patients with current creatinine \\> 1.5mg/dl\n* Patients with history of coagulopathy\n* Patients with history of hepatic impairment\n* Patients with uncontrolled cardiovascular disease",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Doris Tong, MD",
                    "role": "CONTACT",
                    "phone": "(248) 763-2380",
                    "email": "doris.tong@michiganspineandbrainsurgeons.com"
                },
                {
                    "name": "Chad Claus, DO",
                    "role": "CONTACT"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Doris Tong, MD",
                    "affiliation": "Michigan Spine and Brain Surgeons",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Providence-Providence Park, Southfield",
                    "status": "RECRUITING",
                    "city": "Southfield",
                    "state": "Michigan",
                    "zip": "48075",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.47337,
                        "lon": -83.22187
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "30670528",
                    "type": "DERIVED",
                    "citation": "Claus CF, Lytle E, Tong D, Sigler D, Lago D, Bahoura M, Dosanjh A, Lawless M, Slavnic D, Kelkar P, Houseman C, Bono P, Richards B, Soo TM. The effect of ketorolac on posterior thoracolumbar spinal fusions: a prospective double-blinded randomised placebo-controlled trial protocol. BMJ Open. 2019 Jan 21;9(1):e025855. doi: 10.1136/bmjopen-2018-025855."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000020910",
                    "term": "Ketorolac"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000894",
                    "term": "Anti-Inflammatory Agents, Non-Steroidal"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000016861",
                    "term": "Cyclooxygenase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M22645",
                    "name": "Ketorolac",
                    "asFound": "Esophageal",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4218",
                    "name": "Anti-Inflammatory Agents, Non-Steroidal",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M19209",
                    "name": "Cyclooxygenase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}